Insider Trading History of Mayer Eldon C. Iii

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Mayer Eldon C. Iii since 2018. This trader's CIK number is 1686952. At the time of last reporting, Mayer Eldon C. Iii was the Ex VP & Chief Commerc. Officer of Eiger Biopharmaceuticals, Inc.. (stock ticker symbol EIGR). Also see all insider trading activities at Eiger Biopharmaceuticals, Inc..

Note that in the past Mayer Eldon C. III also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Eiger Biopharmaceuticals, Inc. (EIGR) by Mayer Eldon C. Iii

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 EIGR 0 $0 4,395 $4,702 0 $0
2022 EIGR 0 $0 3,217 $16,996 0 $0
2021 EIGR 0 $0 1,690 $19,739 0 $0
2020 EIGR 5,000 $67,605 0 $0 0 $0
2018 EIGR 25,000 $248,836 0 $0 0 $0

Yearly summary of insider trading at Rigel Pharmaceuticals Inc (RIGL) by Mayer Eldon C. Iii

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 RIGL 200,000 $607,850 0 $0 0 $0


Insider trading activities at 2 companies by Mayer Eldon C. Iii:

1. Eiger Biopharmaceuticals, Inc. (EIGR)

2. Rigel Pharmaceuticals Inc (RIGL)

Table 1. Insider trading of Eiger Biopharmaceuticals, Inc. (EIGR) by Mayer Eldon C. Iii

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-03-17 EIGR Sale 4,395 1.07 4,702
2022-03-14 EIGR Sale 1,657 5.60 9,274
2022-01-07 EIGR Sale 1,560 4.95 7,722
2021-01-08 EIGR Sale 1,690 11.68 19,739
2020-01-24 EIGR Buy 5,000 13.52 67,605
2018-11-29 EIGR Buy 4,000 10.21 40,840
2018-11-26 EIGR Buy 7,500 9.75 73,140
2001-11-28 EIGR Buy 6,000 10.07 60,449
2018-11-27 EIGR Buy 7,500 9.92 74,407

Table 2. Insider trading of Rigel Pharmaceuticals Inc (RIGL) by Mayer Eldon C. Iii

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-09-10 RIGL Buy 50,000 3.28 164,200
2018-09-11 RIGL Buy 50,000 3.23 161,350
2018-08-23 RIGL Buy 100,000 2.82 282,300

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mayer Eldon C. Iii (Ex VP & Chief Commerc. Officer of Eiger Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.